B-ABSSSI Phase 2b results unblinded within about 4 weeks. B-OM Phase 2/3a trial starting within a few weeks. K Phase 1 dosing at 350 mg/m^2 still with no reported DLTs after a month. K w/Cytarabine Phase 1b AML starting at University of Bologna in the next few weeks P Phase 2/3a starting around the coming first quarter.
4 drugs in 5 clinical trials and all already funded. Not budgeted, funded. Link to ongoing and completed trials: